Terms: = Brain cancer AND NOTCH1, TAN1, P46531, 4851, ENSG00000148400, hN1
196 results:
1. notch1-Related Leukoencephalopathy: A Novel Variant and Literature Review.
Della Vecchia S; Tessa A; Pasquariello R; Seabra L; Crow YJ; Battini R
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474113
[No Abstract] [Full Text] [Related]
2. Sirtuin 3 regulates astrocyte activation by reducing notch1 signaling after status epilepticus.
Zhu J; Park S; Kim SH; Kim CH; Jeong KH; Kim WJ
Glia; 2024 Jun; 72(6):1136-1149. PubMed ID: 38406970
[TBL] [Abstract] [Full Text] [Related]
3. cancer-associated fibroblasts-induced remodeling of tumor immune microenvironment via Jagged1 in glioma.
Zhang Q; Wang J; Zhang J; Wang Y; Wang Y; Liu F
Cell Signal; 2024 Mar; 115():111016. PubMed ID: 38128708
[TBL] [Abstract] [Full Text] [Related]
4. Novel insight into histological and molecular astrocytoma, IDH-mutant, Grade 4 by the updated WHO classification of central nervous system tumors.
Chen W; Guo S; Wang Y; Shi Y; Guo X; Liu D; Li Y; Wang Y; Xing H; Xia Y; Li J; Wu J; Liang T; Wang H; Liu Q; Jin S; Qu T; Li H; Yang T; Zhang K; Wang Y; Ma W
Cancer Med; 2023 Sep; 12(18):18666-18678. PubMed ID: 37667984
[TBL] [Abstract] [Full Text] [Related]
5. Targeting EZH2 regulates the biological characteristics of glioma stem cells via the notch1 pathway.
Zhao G; Deng Z; Li X; Wang H; Chen G; Feng M; Zhou Y
Exp Brain Res; 2023 Oct; 241(10):2409-2418. PubMed ID: 37644332
[TBL] [Abstract] [Full Text] [Related]
6. FAM129A promotes self-renewal and maintains invasive status via stabilizing the Notch intracellular domain in glioma stem cells.
Liu G; Zhang P; Chen S; Chen Z; Qiu Y; Peng P; Huang W; Cheng F; Zhang Y; Li H; Xiao Q; Mao F; Wang B; Jiang X; Wan F; Guo D; Yu X
Neuro Oncol; 2023 Oct; 25(10):1788-1801. PubMed ID: 37083136
[TBL] [Abstract] [Full Text] [Related]
7. Hypocretin-1 suppresses malignant progression of glioblastoma cells through notch1 signaling pathway.
Huan R; Yue J; Lan J; Wang J; Cheng Y; Zhang J; Tan Y
Brain Res Bull; 2023 May; 196():46-58. PubMed ID: 36925051
[TBL] [Abstract] [Full Text] [Related]
8. Immunological profiles of human oligodendrogliomas define two distinct molecular subtypes.
Wu F; Yin YY; Fan WH; Zhai Y; Yu MC; Wang D; Pan CQ; Zhao Z; Li GZ; Zhang W
EBioMedicine; 2023 Jan; 87():104410. PubMed ID: 36525723
[TBL] [Abstract] [Full Text] [Related]
9. Mesenchymal-endothelial nexus in breast cancer spheroids induces vasculogenesis and local invasion in a CAM model.
Li A; Muenst S; Hoffman J; Starck L; Sarem M; Fischer A; Hutter G; Shastri VP
Commun Biol; 2022 Nov; 5(1):1303. PubMed ID: 36435836
[TBL] [Abstract] [Full Text] [Related]
10. Thyroid carcinoma metastases to central nervous system and vertebrae.
Kleinschmidt-DeMasters B; Marshall C
Folia Neuropathol; 2022; 60(3):292-300. PubMed ID: 36382481
[TBL] [Abstract] [Full Text] [Related]
11. ADAMTS1 as potential prognostic biomarker promotes malignant invasion of glioma.
Wang S; Zhang J; Wang K; Zhao Y; Liu D
Int J Clin Oncol; 2023 Jan; 28(1):52-68. PubMed ID: 36371587
[TBL] [Abstract] [Full Text] [Related]
12. Atypical induction of HIF-1α expression by pericellular notch1 signaling suffices for the malignancy of glioblastoma multiforme cells.
Lee J; Kim E; Chong K; Ryu SW; Kim C; Choi K; Kim JH; Choi C
Cell Mol Life Sci; 2022 Oct; 79(10):537. PubMed ID: 36183290
[TBL] [Abstract] [Full Text] [Related]
13. miR-30c plays diagnostic and prognostic roles and mediates epithelial-mesenchymal transition (EMT) and proliferation of gliomas by affecting notch1.
Li M; Liu W; Li J; Zhang H; Xu J
Sci Rep; 2022 Sep; 12(1):16404. PubMed ID: 36180477
[TBL] [Abstract] [Full Text] [Related]
14. Engineered Nanoerythrocytes Alleviate Central Nervous System Inflammation by Regulating the Polarization of Inflammatory Microglia.
Yin N; Zhao Y; Liu C; Yang Y; Wang ZH; Yu W; Zhang K; Zhang Z; Liu J; Zhang Y; Shi J
Adv Mater; 2022 Jul; 34(27):e2201322. PubMed ID: 35483045
[TBL] [Abstract] [Full Text] [Related]
15. NSG-70, a new glioblastoma cell line with mixed proneural-mesenchymal features, associates notch1-WNT5A signaling with stem cell maintenance and angiogenesis.
Singh DK; Shivalingappa PKM; Sharma A; Mondal A; Muzumdar D; Shiras A; Bapat SA
J Neurooncol; 2022 May; 157(3):575-591. PubMed ID: 35430703
[TBL] [Abstract] [Full Text] [Related]
16. Overexpression of FOXD2-AS1 enhances proliferation and impairs differentiation of glioma stem cells by activating the NOTCH pathway via TAF-1.
Wang Y; Cheng Y; Yang Q; Kuang L; Liu G
J Cell Mol Med; 2022 May; 26(9):2620-2632. PubMed ID: 35419917
[TBL] [Abstract] [Full Text] [Related]
17. Monoallelic
Veiga DFT; Tremblay M; Gerby B; Herblot S; Haman A; Gendron P; Lemieux S; Zúñiga-Pflücker JC; Hébert J; Cohen JP; Hoang T
Front Immunol; 2022; 13():867443. PubMed ID: 35401501
[TBL] [Abstract] [Full Text] [Related]
18. Patient-individual phenotypes of glioblastoma stem cells are conserved in culture and associate with radioresistance, brain infiltration and patient prognosis.
Ganser K; Eckert F; Riedel A; Stransky N; Paulsen F; Noell S; Krueger M; Schittenhelm J; Beck-Wödl S; Zips D; Ruth P; Huber SM; Klumpp L
Int J Cancer; 2022 May; 150(10):1722-1733. PubMed ID: 35085407
[TBL] [Abstract] [Full Text] [Related]
19. Surgical resection of glioblastomas induces pleiotrophin-mediated self-renewal of glioblastoma stem cells in recurrent tumors.
Knudsen AM; Halle B; Cédile O; Burton M; Baun C; Thisgaard H; Anand A; Hubert C; Thomassen M; Michaelsen SR; Olsen BB; Dahlrot RH; Bjerkvig R; Lathia JD; Kristensen BW
Neuro Oncol; 2022 Jul; 24(7):1074-1087. PubMed ID: 34964899
[TBL] [Abstract] [Full Text] [Related]
20. A tale of two multi-focal therapies for glioblastoma: An antibody targeting ELTD1 and nitrone-based OKN-007.
Zalles M; Smith N; Saunders D; Lerner M; Fung KM; Battiste J; Towner RA
J Cell Mol Med; 2022 Jan; 26(2):570-582. PubMed ID: 34910361
[TBL] [Abstract] [Full Text] [Related]
[Next]